DD299062A5 - Verwendung von pteridinen und verfahren zu deren herstellung - Google Patents

Verwendung von pteridinen und verfahren zu deren herstellung Download PDF

Info

Publication number
DD299062A5
DD299062A5 DD89333128A DD33312889A DD299062A5 DD 299062 A5 DD299062 A5 DD 299062A5 DD 89333128 A DD89333128 A DD 89333128A DD 33312889 A DD33312889 A DD 33312889A DD 299062 A5 DD299062 A5 DD 299062A5
Authority
DD
German Democratic Republic
Prior art keywords
group
methyl
morpholino
propyl
pteridine
Prior art date
Application number
DD89333128A
Other languages
German (de)
English (en)
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD299062A5 publication Critical patent/DD299062A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD89333128A 1988-10-01 1989-09-29 Verwendung von pteridinen und verfahren zu deren herstellung DD299062A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD299062A5 true DD299062A5 (de) 1992-03-26

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89333128A DD299062A5 (de) 1988-10-01 1989-09-29 Verwendung von pteridinen und verfahren zu deren herstellung

Country Status (19)

Country Link
EP (1) EP0362645B1 (ru)
JP (1) JPH02256676A (ru)
KR (1) KR910006289A (ru)
AT (1) ATE106728T1 (ru)
AU (1) AU620645B2 (ru)
DD (1) DD299062A5 (ru)
DE (2) DE3833393A1 (ru)
DK (1) DK480489A (ru)
ES (1) ES2056174T3 (ru)
FI (1) FI92699C (ru)
HU (1) HU205761B (ru)
IL (1) IL91814A (ru)
MX (1) MX9203034A (ru)
NO (1) NO175979C (ru)
NZ (1) NZ230833A (ru)
PT (1) PT91836B (ru)
SU (1) SU1720491A3 (ru)
UA (1) UA8028A1 (ru)
ZA (1) ZA897414B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
ATE277929T1 (de) * 1998-12-28 2004-10-15 4 Aza Bioscience Nv Immunsuppressive wirkungen von pteridinderivaten
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE602004008304T2 (de) * 2003-09-12 2008-05-08 4 Aza Ip Nv Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
PT1673092E (pt) * 2003-10-17 2007-11-23 4 Aza Ip Nv ''derivados de pteridina substituídos com heterociclos e sua utilização em terapia''
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
EP3097102B1 (en) 2015-03-04 2017-10-18 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
EP3507276B1 (en) 2016-09-02 2021-11-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (ru) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
AU4174989A (en) 1990-04-05
FI894615A (fi) 1990-04-02
IL91814A (en) 1994-02-27
FI894615A0 (fi) 1989-09-29
DE3833393A1 (de) 1990-04-05
SU1720491A3 (ru) 1992-03-15
JPH02256676A (ja) 1990-10-17
FI92699C (fi) 1994-12-27
PT91836A (pt) 1990-04-30
NO893879D0 (no) 1989-09-29
EP0362645A3 (de) 1992-03-25
UA8028A1 (ru) 1995-12-26
DK480489D0 (da) 1989-09-29
AU620645B2 (en) 1992-02-20
KR910006289A (ko) 1991-04-29
NO893879L (no) 1990-04-02
HUT52504A (en) 1990-07-28
ZA897414B (en) 1991-06-26
HU205761B (en) 1992-06-29
EP0362645B1 (de) 1994-06-08
IL91814A0 (en) 1990-06-10
NO175979C (no) 1995-01-11
ES2056174T3 (es) 1994-10-01
FI92699B (fi) 1994-09-15
PT91836B (pt) 1995-07-18
MX9203034A (es) 1992-07-01
EP0362645A2 (de) 1990-04-11
DE58907824D1 (de) 1994-07-14
NZ230833A (en) 1991-05-28
ATE106728T1 (de) 1994-06-15
DK480489A (da) 1990-04-02
NO175979B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
EP1599478B1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69202243T2 (de) 2,4-Diaminochinazolin-Derivate, um die Antitumorwirkung zu erhöhen.
DD299062A5 (de) Verwendung von pteridinen und verfahren zu deren herstellung
EP2176266A2 (de) Substituierte imidazo[1,2b]pyridazine als kinase-inhibitoren, deren herstellung und verwendung als arzneimittel
DE60302221T2 (de) Heteroaryl substituierte 2-pyridinyl und 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-onderivate
CN108069946B (zh) 具有穿过血脑屏障能力的取代的喹唑啉化合物
JPS5865267A (ja) スルホンアミド誘導体、その製法及びそれを含む医薬組成物
CH616677A5 (ru)
EP1632493A1 (de) Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE60103909T2 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
DE69533194T2 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
DE19636769A1 (de) 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE10202468A1 (de) Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DD295088A5 (de) Verwendung von aryl-substituierten aminderivaten zur herstellung von arzneimitteln und verfahren zu ihrer herstellung
DE3788195T2 (de) DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
DE60104130T2 (de) 1-(alkyl), 1-[(heteroaryl)alkyl] und 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-onderivate
EP0645390A1 (de) Trisubstituierte Pyrimido/5,4-d/-pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69612753T2 (de) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, verfahren zu seinerherstellung und dieses enthaltende medizinische zubereitung
CH643549A5 (de) N-(trimethoxybenzyl)-n'-phenylpiperazine.
DE4009941A1 (de) Verwendung von pteridinen zur sensibilisierung resistenter plasmodien bei der malaria-chemotherapie und diese verbindungen enthaltende arzneimittel
DE2753791C2 (ru)
EP0589908B1 (de) Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung
DE69024385T2 (de) Verbindung zur Behandlung von Störungen des Neurotransmittersystems im Gehirn
DE4225353A1 (de) Neue Pteridine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee